We've successfully predicted more than 40 price sensitive events - before they happened.

Deal predictions

A one-stop shop for all your restructuring needs 

Distressed and Restructuring

AI transcripts & instant analysis, making earnings season easier than ever.

Earnings

Benchmark prior transactions, bonds, loans or company profiles using over 300 credit metrics.

Comparables

New deal analysis & covenant comparison tools, understand key risks in seconds not days.

Covenants

We use AI to aggregate newsflow from 2,000 sources, and deliver it to your inbox quicker than anyone else.

News

Say goodbye to CTRL + F with our powerful search. Thousands of documents text searchable for any keyword or phrase.

Search

Full Financial profiles with 3 statements, KPIs, segment splits & credit metrics. All traced to source documents.

Financials

A full suite of ESG data and analysis. Built for your workflow

Track high yield deals from issuance through to maturity, with integrated legal, credit and ESG analysis.

High Yield Bonds

Shine a light on private markets with 9fin's news and legal analysis of syndicated loans

Leveraged Loans

Find information others can't see in one of the fastest growing corners of finance

Private Credit 

Unlock new business with the most impactful CLO market content married with elegant data analysis tools.

Structured Credit 

Emmet Mc Nally

David Orbay-Graves

Upfield (Flora Food) delivered on-target Q4 22 and FY 22 earnings yesterday evening (29 March), with revenue and EBITDA in line with expectations. Leverage came in below our estimates, and Q4 22 liquidity was such that the company could afford to repurchase a combined €250m-equivalent of their PLN-denominated and GBP-denominated TLBs in February.

The positive response in bond prices thus far has been less pronounced than was seen following Q2 and Q3 22 earnings, as we had predicted as of Q3 22. The €685m 5.75% 2026 SUNs and $525m 7.875% 2026 SUNs are both up ~4.5 points since earnings landed, as of writing. This alters the pattern seen in the two previous quarters.

The 2023 earnings outlook doesn’t look much changed from November, with management guiding to mid-single digit sales growth, continued EBITDA growth and further de-leveraging. Input cost inflation is expected to persist in the near-term, but the annualisation of 2022 pricing initiatives still has a big part to play in H1 23 in particular.

Perhaps the most notable development from earnings was the fact the company opted to pay down €60m-equivalent of its sterling TLB and €190m-equivalent of its PLN-denominated TLB in February 2023.

Unrestricted cash at Q4 22 was €187m and Q1 is not typically a seasonally strong quarter, so it is therefore reasonable to assume the company partly drew down its €700m RCF (€40m drawn at Q4 22) to help fund the TLB repurchases. The company noted in its Q4 22 financial report that: “We will continue to utilise the RCF to support overall liquidity consistent with the general seasonality of the business.”

Management did not state how the redemptions were funded, but the notes to the financial statements state that the solicitation process to reduce the loans was done “using financial headroom”. There was certainly plenty of headroom under the 40% springing covenant on the RCF with senior secured net leverage at 5.6x vs a cap of 8.5x.

Asked about the repayments on the call, CFO, Florence Naviner said the repayment had a “very good economic benefit” and that the choice of tranches was down to cost and favourable currency. She went on to say that management expects to generate similar levels of cash in 2023, and hopes that there is capacity every year to repay some debt.

Separately, Naviner confirmed that floating rate interest hedging had gradually increased to 67% as of now from 45% at Q3 22. There will be a small rise in interest costs as a result of the lower level of hedging vs 2022, but it will be “relatively controlled”.

Inflation concerns no longer dictating performance

The company has proven it can handle inflationary pressures and has a good degree of pricing power. Concerns regarding input cost inflation were more prevalent in the lead up to Q2 and Q3 22 earnings with less clarity on whether pricing could keep up.

Confirmation that pricing could indeed keep up, particularly in Q3 22, was likely the main driver of the bond price appreciation following both sets of results. We suggested the trend was less likely to repeat at Q4 earnings with less concern now around profitability.

That said, bond prices in the high-70s/low-80s now, from the mid-60s before Q2 22 earnings in August, is clearly indicative that Upfield’s credit profile has sustainability improved. From here, bond performance is likely to be more driven by the inherent refinancing risk, we suggest, with the company’s ability to continue to de-leverage firmly in focus.

On the outlook for pricing, CEO, David Haines, revealed on the call that all but one large European contract was agreed for 2023, with two large European customer agreements reached in the past 48 hours. Some are six-month agreements, but by-and-large 2023 contracts are agreed, he said.

This should offer a good degree of visibility in terms of the outlook for 2023 and management appeared confident on the commercial dynamics. This is in the context of softening edible oil prices, but management is not expecting any net commodity input cost decreases in 2023 with many costs, such as energy and refinery costs, still inflating.

Q4 22 revenue of €991m was broadly expected, with management guiding to high-teens FY 22 revenue growth at Q3 22. FY 22 came in at €3,375m, a 20.8% YoY increase or 18.5% at constant currency.

Pricing contributed 36.5% to Q4 22 revenue with volume and mix offsetting by 14%. That meant that for FY 22 in total, revenue was boosted 29% by pricing and hit with a 10.5% volume and mix impact, of which 6.5% was underlying.

Q4 22 EBITDA also came in line with our expectations at €248m (25% margin). FY 22 EBITDA of €749m at a 22.2% margin was a 12.5% YoY nominal improvement, but the margin suffered a 160bps decline on account of inflation outpacing pricing in H1 22.

Year-end leverage of 7.2x was a strong print, as typically seasonally strong cash flows were boosted by €60m proceeds in Q4 from the sale of PP&E. €271m of Q4 22 FCF (9fin definition) provided the windfall needed to pay down the RCF to only €40m drawn from €279m as of Q3 22.

As mentioned above, the company had ample room under a 40% springing covenant on the RCF with senior secured net leverage of 5.6x well below the cap of 8.5x.

Guidance for next year was limited: net sales is expected to experience mid-single digit growth, EBITDA is expected to grow (unquantified) and leverage to reduce. Pushed during the Q&A, management declined to give a specific target for leverage in FY 23.

We are currently working with a base case of ~5% revenue growth and normalised EBITDA in the €800m - €820m range. FY 23 leverage of 6.3x is a decent target, after FCF of €200m - €250m.

The annualisation of pricing still has a big part to play in H1 23 and we expect the YoY comparison to look strong as pricing lagged inflation by some margin in H1 22.

Upfield delivers on FY 22 targets, improves leverage and pays down some TLB – Q4 22 earnings review

Read all our public content for free

Recently Published

Taking the Credit — Opportunities are slender with an incumbent lender

European LevFin Wrap — Dash for divis but no sight of Synlab

Friday Workout — Glide paths; sending out a distress Signa(l)

Excess Spread — Switched on, feeding the beast, senior year

What are you waiting for?

Cookies & Privacy